Investors' high expectations for Inner Mongolia Furui Medical Science's revenue performance may be driving its high P/S ratio. The strong share price surge and confidence in future revenues are keeping the P/S elevated. A significant share price drop seems unlikely under these conditions.

The high P/S ratio of Inner Mongolia Furui Medical Science Co. hints at expected revenue upturn. Yet, with growth forecasts just meeting industry average, the lofty ratio may be unwarranted, possibly causing letdowns if it aligns more with growth prospects.

The company is highly valued for its 5-year earnings growth streak, evident in its notable P/E ratio of 97.78. Its 109% total shareholder return over the past year points to a favorable market sentiment.